ES2059106T3 - Solucion de infusion de mitonafide. - Google Patents

Solucion de infusion de mitonafide.

Info

Publication number
ES2059106T3
ES2059106T3 ES91900238T ES91900238T ES2059106T3 ES 2059106 T3 ES2059106 T3 ES 2059106T3 ES 91900238 T ES91900238 T ES 91900238T ES 91900238 T ES91900238 T ES 91900238T ES 2059106 T3 ES2059106 T3 ES 2059106T3
Authority
ES
Spain
Prior art keywords
mitonafide
infusion solution
infusion
solution
mitonafides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900238T
Other languages
English (en)
Inventor
Christine Tetzner
Jimenez Miguel Martin
Costa Rafael Rosell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Application granted granted Critical
Publication of ES2059106T3 publication Critical patent/ES2059106T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBE UNA SOLUCION PARA INFUSIONES QUE CONTIENE MITONAFIDAS.
ES91900238T 1989-11-29 1990-11-26 Solucion de infusion de mitonafide. Expired - Lifetime ES2059106T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939372A DE3939372A1 (de) 1989-11-29 1989-11-29 Mitonafide-infusionsloesung

Publications (1)

Publication Number Publication Date
ES2059106T3 true ES2059106T3 (es) 1994-11-01

Family

ID=6394369

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900238T Expired - Lifetime ES2059106T3 (es) 1989-11-29 1990-11-26 Solucion de infusion de mitonafide.

Country Status (6)

Country Link
EP (1) EP0502936B1 (es)
JP (1) JPH05503079A (es)
CA (1) CA2059528A1 (es)
DE (2) DE3939372A1 (es)
ES (1) ES2059106T3 (es)
WO (1) WO1991007965A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635930A1 (de) * 1986-10-22 1988-04-28 Basf Ag Wirkstoffe zur anwendung bei der behandlung von tumoren
DE3635711A1 (de) * 1986-10-21 1988-04-28 Knoll Ag 5-nitrobenzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung
DE3707652A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Verwendung von benzo(de)isochinolin-1,3-dionen zur herstellung von arzneimitteln

Also Published As

Publication number Publication date
DE59002122D1 (de) 1993-09-02
EP0502936B1 (de) 1993-07-28
WO1991007965A1 (de) 1991-06-13
EP0502936A1 (de) 1992-09-16
JPH05503079A (ja) 1993-05-27
CA2059528A1 (en) 1991-05-30
DE3939372A1 (de) 1991-06-06

Similar Documents

Publication Publication Date Title
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
ES2097802T3 (es) Solucion tampon de histidina para dialisis peritoneal.
GR890100838A (el) Νέα ?εραπευτικώς δραστική ένωσις και μέ?οδος για την παραγωγή της.
ES2044840T3 (es) Composiciones estabilizadas del activador del plasminogeno de tejido humano.
IT8821542A0 (it) Composti attivi come inibitori della biosintesi del colesterolo.
DE69012888D1 (de) Plasminogenaktivator.
NO165769C (no) Flytende blekepreparat.
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
ES2194003T3 (es) Huperzina a racemica.
NO890505D0 (no) Vandig blekepreparat.
ES2061995T3 (es) Preparacion de una dimetiltetralina.
NO890503L (no) Vandig blekemiddel.
ES8403623A1 (es) Procedimiento para la determinacion de bilirrubina directa y total en liquidos corporales.
NO893375D0 (no) Nye antiarytmiske midler i.
ES2068350T3 (es) Acidos oxoftalazinilaceticos sustituidos y analogos de los mismos.
ES2043614T3 (es) Procedimiento para la preparacion de un compuesto bactericida.
ES2058141T3 (es) Utilizacion de gamma-glutamil-transpeptidasa.
GR880100869A (el) Μέ?οδος παρασκευής παραγώγων υποκατεστημένου στυρολίου.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ES2059106T3 (es) Solucion de infusion de mitonafide.
ES2074812T3 (es) Composicion liquida para lavavajillas.
SE8803182L (sv) Snabbloesbar koppling
ES2057000T3 (es) Procedimiento para la determinacion de tiroxina y solucion tipo standard adecuada para el mismo.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ES2059860T3 (es) Oxirano-fenilesteres y los fungicidas que les contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 502936

Country of ref document: ES